Litcius/Paper detail

ANP32E promotes esophageal cancer progression and paclitaxel resistance via P53/SLC7A11 axis-regulated ferroptosis

Li‐Ying Sun, Shaobo Ke, Boxin Li, Fei-Shan Chen, Zhi‐Qun Huang, Le Li, Jianfeng Zhang, Yuxin Cai, Yu-Xin Cai, Xiaodong Zhang, Run-Lei Du, Yi Liu, Yongshun Chen, Yongshun Chen

2024International Immunopharmacology14 citationsDOI

Topics & Concepts

PaclitaxelEsophageal cancerCancer researchResistance (ecology)CancerChemistryBiologyMedicineInternal medicineEcologyFerroptosis and cancer prognosisRNA modifications and cancerEpigenetics and DNA Methylation
ANP32E promotes esophageal cancer progression and paclitaxel resistance via P53/SLC7A11 axis-regulated ferroptosis | Litcius